Maxwellia is backed by Praetura Ventures, Catapult Ventures / GM&C Life Sciences Fund, BioCity, Alderley Park Ventures, Robert Wilson (Chair) and a group of EIS angel investors.
March 2021 share offer
CLOSED
We raised £3.2m to support the launch of our first ground breaking Women’s Health brand in an exciting new £327m category opportunity and to further build our pipeline of Self Care innovation.
